Bio-Rad Laboratories, Inc. (BIO) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Bio-Rad Laboratories, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
10.87
Strong
WeakModerateStrong
P/B Ratio
1.11
Strong
WeakModerateStrong
Earnings Yield
9.20%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
10.20%
Moderate
WeakModerateStrong
Operating Margin
10.47%
Moderate
WeakModerateStrong
Net Profit Margin
29.42%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
0.65%
Weak
WeakModerateStrong
Net Income Growth
141.20%
Strong
WeakModerateStrong
EPS Growth
142.64%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
5.62
Strong
WeakModerateStrong
Quick Ratio
4.19
Strong
WeakModerateStrong
Asset Turnover
0.24x
Weak
WeakModerateStrong
Inventory Turnover
1.67x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
4.53%
Strong
WeakModerateStrong
EV / Free Cash Flow
24.72x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.80x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
3.680
Strong
WeakModerateStrong
Return on Invested Capital
2.04%
Weak
WeakModerateStrong
Cash Conversion Cycle
246.88 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for BIO.
View Financial Statements